Table 2.
Virus
|
Public health priorities
|
Research priorities
|
Hepatitis A | Increased vaccination of high-risk individuals; Improved sanitation and vaccination in camps for displaced persons | Medical treatments for those with acute liver failure |
Hepatitis B | Increase uptake of vaccination; Identifying undiagnosed individuals; Linkage to care | Establishing treatment end-points; Identifying curative treatment |
Hepatitis C | Microelimination; Reducing re-infection rates; Identifying undiagnosed individuals; Harm reduction | Vaccination; Confirming most effective HCC surveillance strategies |
Hepatitis D | Identification of infected individuals; Clarifying current disease burden of HDV | Novel therapies |
Hepatitis E | Increased screening of blood products/change in donor policies; Educating immunosuppressed patients of risk of food-borne transmission; Further understanding of sources of infection | RCT to confirm optimal dose and duration of ribavirin therapy; Novel treatments; Vaccination; Greater understanding of genetic mutations |
HDV: Hepatitis D virus; HCC: Hepatocellular carcinoma; RCT: Randomized controlled trial.